MUENSTER, Lukas, Zdenka CAPAKOVA, Petr HUMPOLICEK, Ivo KURITKA, Bjorn E CHRISTENSEN and Jan VICHA. Dicarboxylated hyaluronate: Synthesis of a new, highly functionalized and biocompatible derivative. Carbohydrate Polymers. Oxford: ELSEVIER SCI LTD, 2022, vol. 292, SEP, p. 119661-119673. ISSN 0144-8617. Available from: https://dx.doi.org/10.1016/j.carbpol.2022.119661.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Dicarboxylated hyaluronate: Synthesis of a new, highly functionalized and biocompatible derivative
Authors MUENSTER, Lukas, Zdenka CAPAKOVA, Petr HUMPOLICEK, Ivo KURITKA, Bjorn E CHRISTENSEN and Jan VICHA.
Edition Carbohydrate Polymers, Oxford, ELSEVIER SCI LTD, 2022, 0144-8617.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10400 1.4 Chemical sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 11.200
RIV identification code RIV/00216224:14740/22:00128756
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.carbpol.2022.119661
UT WoS 000818379000005
Keywords in English Sodium hyaluronate; Selective oxidation; Periodate oxidation; Chlorite oxidation; Dicarboxylated hyaluronate; Cisplatin
Tags CF NMR, ne MU, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 28/2/2023 14:33.
Abstract
Sequential periodate-chlorite oxidation of sodium hyaluronate to 2,3-dicarboxylated hyaluronate (DCH), a novel biocompatible and highly functionalized derivative bearing additional pair of -COOH groups at C2 and C3 carbons of oxidized ?-glucuronic acid units, is investigated. The impact of various reaction parameters (time, oxidizer concentration, and molar amount) on DCH's composition, molecular weight, degree of oxidation, and cytotoxicity are investigated to guide the synthesis of DCH derivatives of desired properties. Subsequently, fully (99%) and partially (70%) oxidized DCH derivatives were compared to untreated sodium hyaluronate in terms of anticancer drug cisplatin loading efficacy, carrier capacity, drug release rates, and cytotoxicity towards healthy and cancerous cell lines. DCH derivatives were found to be superior in every aspect, having nearly twice the carrier capacity, significantly slower release rates, and higher efficacy. DCH is thus a highly interesting hyaluronate derivative with an adjustable degree of oxidation, molecular weight, and great potential for further modifications.
Links
90127, large research infrastructuresName: CIISB II
PrintDisplayed: 12/7/2024 23:05